Incidence of benign pathology in patients undergoing hepatic resection for suspected malignancy

Clayton, R.A.E.; Clarke, Damian; Currie, Elspeth J.; Madhavan, K.K.; Parks, RW; Garden, O. James

doi:10.1016/s1479-666x(03)80006-9

Cited by 81 publications

(47 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Early and accurate diagnosis is essential, and impacts not only patients' outcome but also possible surgical treatments and targeted chemotherapies. From 13% to 24% of patients with presumed hilar cholangiocarcinoma are found to have benign disease at surgery [15,16], and precise diagnosis is essential to avoid unnecessary surgery for patients with benign strictures.…”

Section: Diagnostic Applicationsmentioning

confidence: 99%

Peroral Cholangiopancreatoscopy with the SpyGlass® System: What do we Know 10 Years Later

Pereira

Peixoto

Andrade

et al. 2017

JGLD

View full text Add to dashboard Cite

Smaller endoscopes and catheters have been developed that permit direct visualization of the bile and pancreatic ducts (cholangioscopy and pancreatoscopy, respectively). These endoscopes and catheters are passed through the working channel of a standard therapeutic duodenoscope during endoscopic retrograde cholangiopancreatography (ERCP). The SpyGlass Direct Visualization System (Boston Scientific Corp, Natick, MA, USA) is currently the most widely used and studied device. Cholangioscopy with intraductal lithotripsy has become an established modality in the treatment of difficult biliary lithiasis. When used in the evaluation of indeterminate biliary strictures by experienced endoscopists in recognizing intraductal pathology, it increases the diagnostic yield of tissue sampling. Pancreatoscopy is complementary to other imaging modalities in the evaluation of intraductal papillary mucinous neoplasms of the pancreas and is emerging as a sole or adjunctive therapy to extracorporeal shock wave lithotripsy for the treatment of main pancreatic duct stones. It remains investigational in the diagnosis of pancreatic adenocarcinoma. Complications specific to the performance of cholangiopancreatoscopy include cholangitis, which is related to intraductal fluid irrigation.Abbreviations: EHL: Electrohydraulic lithotripsy; ERCP: Endoscopic retrograde cholangiopancreatography; ESWL: Extracorporeal lithotripsy by shock waves; ET: Endoscopic therapy; EUS: Endoscopic ultrasound; IPMN: intraductal papillary mucinous neoplasm; LL: Laser lithotripsy; MDCT: Multi-detector computed conventional tomography; MPD: Main pancreatic duct; MRCP: Magnetic resonance cholangiopancreatography; MRI: Magnetic resonance imaging; POCPS: Peroral cholangiopancreatoscopy; PSC: Primary sclerosing cholangitis

show abstract

Section: Diagnostic Applicationsmentioning

confidence: 99%

Peroral Cholangiopancreatoscopy with the SpyGlass® System: What do we Know 10 Years Later

Pereira

Peixoto

Andrade

et al. 2017

JGLD

View full text Add to dashboard Cite

show abstract

“…66,67 Therefore, accurate preoperative diagnosis is paramount to avoiding unnecessary surgery, and patients with suspected cholangiocarcinoma should preferably have a confirmatory cytopathologic diagnosis before curative radical resection is attempted. Although pancreaticoduodenectomy (Whipple resection) is required for surgical resection of distal cholangiocarcinoma, partial hepatectomies are frequently performed for treatment of perihilar (Klatskin) tumors.…”

Section: Eus-fna For Diagnosis Of Cholangiocarcinomamentioning

confidence: 99%

Utility of EUS in patients with indeterminate biliary strictures and suspected extrahepatic cholangiocarcinoma (with videos)

Khashab

Fockens

Al‐Haddad

2012

Gastrointestinal Endoscopy

View full text Add to dashboard Cite

“…Indeed, in a large surgical series, benign disease was diagnosed in 24% of patients undergoing surgery for presumed hilar CCAs (8). Differentiation of biliary tract tumors or pseudotumors from CCAs permits optimal patient treatment.…”

Section: Introductionmentioning

confidence: 99%

Mimics of Cholangiocarcinoma: Spectrum of Disease

et al. 2008

View full text Add to dashboard Cite

Cholangiocarcinoma is the second most common primary malignant hepatobiliary neoplasm, accounting for approximately 15% of liver cancers. Diagnosis of cholangiocarcinoma is challenging and the prognosis is uniformly poor, with recurrence rates of 60%-90% after surgical resection. A wide spectrum of neoplastic and nonneoplastic conditions of the biliary tract may masquerade as cholangiocarcinoma, adding to the complexity of management in patients suspected to have cholangiocarcinoma. Mimics of cholangiocarcinoma constitute a heterogeneous group of entities that includes primary sclerosing cholangitis, recurrent pyogenic cholangitis, acquired immunodeficiency syndrome cholangiopathy, autoimmune pancreatitis, inflammatory pseudotumor, Mirizzi syndrome, xanthogranulomatous cholangitis, sarcoidosis, chemotherapy-induced sclerosis, hepatocellular carcinoma, metastases, melanoma, lymphoma, leukemia, and carcinoid tumors. These entities demonstrate characteristic histomorphology and variable clinicobiologic behaviors. The imaging findings of these disparate entities are protean and may be indistinguishable from those of cholangiocarcinoma. In most cases, a definitive diagnosis can be established only with histopathologic examination of a biopsy specimen. © RSNA, 2008 • After reading this article and taking the test, the reader will be able to: List the wide ■ spectrum of biliary tumors and pseudotumors that mimic cholangiocarcinoma. Describe the ■ cross-sectional imaging findings of neoplastic and nonneoplastic conditions of the biliary tract. Discuss how the ■ imaging features of radiologic mimics of cholangiocarcinoma correlate with the pathologic findings. Abbreviations: AIDS = acquired immunodeficiency syndrome, AIP = autoimmune pancreatitis, CCA = cholangiocarcinoma, ERCP = endoscopic retrograde cholangiopancreatography, H-E = hematoxylin-eosin, IPT = inflammatory pseudotumor, PSC = primary sclerosing cholangitis, RPC = recurrent pyogenic cholangitis, 3D = three-dimensional, XGC = xanthogranulomatous cholecystitis RadioGraphics 2008; 28:1115-1129 • Published online 10.1148/rg.284075148 • Content Codes:

show abstract

Incidence of benign pathology in patients undergoing hepatic resection for suspected malignancy

Cited by 81 publications

References 19 publications

Peroral Cholangiopancreatoscopy with the SpyGlass® System: What do we Know 10 Years Later

Peroral Cholangiopancreatoscopy with the SpyGlass® System: What do we Know 10 Years Later

Utility of EUS in patients with indeterminate biliary strictures and suspected extrahepatic cholangiocarcinoma (with videos)

Mimics of Cholangiocarcinoma: Spectrum of Disease

Contact Info

Product

Resources

About